June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Laminin β2 Chain Regulates Retinal Progenitor Cell Behavior Via Dystroglycan
Author Affiliations & Notes
  • Dmitri Serjanov
    Upstate Medical University, Syracuse, New York, United States
    SUNY Eye Institute, Syracuse, New York, United States
  • Galina Bachay
    Upstate Medical University, Syracuse, New York, United States
    SUNY Eye Institute, Syracuse, New York, United States
  • Dale D Hunter
    Upstate Medical University, Syracuse, New York, United States
    SUNY Eye Institute, Syracuse, New York, United States
  • William J Brunken
    Upstate Medical University, Syracuse, New York, United States
    SUNY Eye Institute, Syracuse, New York, United States
  • Footnotes
    Commercial Relationships   Dmitri Serjanov, None; Galina Bachay, None; Dale Hunter, None; William Brunken, None
  • Footnotes
    Support  NEI R01 EY12676 (WJB)
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 112. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Dmitri Serjanov, Galina Bachay, Dale D Hunter, William J Brunken; Laminin β2 Chain Regulates Retinal Progenitor Cell Behavior Via Dystroglycan. Invest. Ophthalmol. Vis. Sci. 2017;58(8):112.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Laminin, a heterotrimeric molecule, is an indispensable organizational component of the extracellular matrix; mutations in laminin genes lead to defective CNS and ocular development in mice and humans. This study investigates the role of laminin β2 chain in regulation of the retinal progenitor cell (RPC) polarity and subsequent proliferation and cell fate adoption. The role of the laminin receptor dystroglycan (DG) was also investigated.

Methods : WT and laminin β2-/- retinas were used. IHC was performed using centrosomal and mitotic markers along with DG and integrin β1 (intβ1). RPC mitotic spindles were visualized via 3D-reconstruction of the dividing RPCs and spindle angles were calculated for each nucleus. DG and integrin β1 expression patterns were assayed and quantified digitally. Organotypic cultures were prepared from P0 retinas. Addition of recombinant b2-containing laminin to the retinal surface was used to rescue Lamb2 deletion ex vivo. Reciprocally, addition of DG function-blocking antibodies was used to block DG-mediated signaling in WT cultures.

Results : Laminin β2 chain deletion results in decreased proliferation and premature RPC pool depletion by P5 (down by 70%; p≤0.01), resulting in underproduction of bipolar cells (down by 38%; p≤0.002) and Müller glia (down by 39%; p≤0.003). This is accompanied by a significant shift of the RPC mitotic spindle pole orientation towards asymmetric (neurogenic) cell divisions at P0 and P3 (p≤0.01). Additionally, down-regulation of DG and intβ1 at the retinal vitreal surface was observed. Addition of exogenous β2-containing laminin trimers to the retinal surface ex vivo restored the normal receptor distribution, spindle orientation, and increased RPC proliferation. Addition of dystroglycan-blocking antibodies to WT organotypic cultures phenocopied laminin β2 deletion, resulting in decreased proliferation and asymmetric mitotic spindle orientation, while intβ1-blocking antibodies had no effect.

Conclusions : These data demonstrate that b2-containing laminins at the ILM regulate critical developmental patterning by regulating matrix receptor expression and RPC behavior such as cytokinesis dynamics and proliferation. DG in particular appears to play an important role in laminin β2-mediated ECM-to-RPC signaling. To our knowledge, this is the first report of dystroglycan signaling affecting mitotic spindle orientation.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×